Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on Charles River Laboratories

Share:
Related CRL
Benzinga's Top Upgrades
Positives In Charles River Labs 'Largely Reflected In Industry-High Valuation'

In a report published Wednesday, Jefferies & Company reiterated its Hold rating on Charles River Laboratories (NYSE: CRL), and raised its price target from $35.00 to $44.00.

Jefferies noted, “3Q results were better than expected, making the narrowed 2012 guidance more conservative. Getting $3 in 2013 EPS requires PCS to continue to outgrow the industry with improving margin. Incremental margin was attractive YoY, but negative sequentially. CRL needs RMS to perform better than in 3Q and share the load with PCS, not hand it off. The AZN deal should help. We raise our PT and 2013 estimates.”

Charles River Laboratories closed on Tuesday at $39.40.

Latest Ratings for CRL

DateFirmActionFromTo
Nov 2016BarclaysUpgradesUnderweightEqual-Weight
Sep 2016UBSDowngradesNeutralSell
Aug 2016CitigroupMaintainsNeutral

View More Analyst Ratings for CRL
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (CRL)

View Comments and Join the Discussion!